ResMed| (RMD) insider trading

By person

17 insiders · 2 transactions

96.5×

Michael Farrell holds 96.5 times base salary in stock. $122.88M of shares against $1.27M in salary for 2026.

Salary from the company's own proxy. The shares are what Michael Farrell last reported holding, valued at $255.00, the price ResMed Common Stock was last bought or sold at on the open market here, on 23 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael J. Farrell

Chairman and CEO

—

$1.13M (1) scheduled

−$1.13M

481,893

0.3341%

$122.88M

+2.9%

Michael J Rider

Global General Counsel

—

$102.00K (1) scheduled

−$102.00K

12,318

0.0085%

$3.14M

+15.6%

Brett Sandercock

Chief Financial Officer

—

83,495

0.0579%

$21.29M

−13.0%

Peter C Farrell

Director

—

51,803

0.0359%

$13.21M

−39.2%

Justin Leong

Chief Product Officer

—

35,489

0.0246%

$9.05M

+27.3%

Ronald R Taylor

Director

—

24,771

0.0172%

$6.32M

+9.5%

Richard Sulpizio

Director

—

17,796

0.0123%

$4.54M

+6.5%

Harjit Gill

Director

—

10,940

0.0076%

$2.79M

+22.2%

Karen Drexler

Director

—

10,602

0.0073%

$2.70M

+25.5%

Kaushik Ghoshal

Chief Commercial Officer, SaaS

—

9,725

0.0067%

$2.48M

−20.2%

Aaron Bloomer

Chief Financial Officer

—

9,072

0.0063%

$2.31M

—

Desney Tan

Director

—

6,002

0.0042%

$1.53M

+56.1%

John Hernandez

Director

—

5,118

0.0035%

$1.31M

+72.8%

Witte Jan De

Director

—

4,261

0.0030%

$1.09M

−43.3%

Christopher DelOrefice

Director

—

2,423

0.0017%

$617.87K

+807.5%

Carol Burt

Director

—

2,156

0.0015%

$549.78K

—

Nicole Mowad-Nassar

Director

—

777

0.0005%

$198.14K

—

ResMed|

What the insiders did Scheduled selling only

By person